Axis Spine Technologies raised £2.2 million (~USD $3.1 million) in a funding round. Axis is developing the next generation of Anterior Spinal Implant technology which provides surgeons with increased correction and alignment options.
The modular devices are inserted with less force than conventional implants to reduce the risks of structural damage which can lead to subsidence, an under-reported and recognized complication.
In 2020, the company received £830,000 (~USD $1.0 million) in new funding to bring products to the spine market, followed by FDA 510(k) clearance to market Axis-ALIF, their first implant system.
The funding will be used to support product launch and also development of oblique and lateral cage implants, as well as a highly differentiated access system.
Jon Arcos, Founder and CEO of Axis, said, “In 2021 we will take a big step forward in our mission to help surgeons improve the spinal care they provide to their patients. Our products will enable them to achieve superior correction and to maintain this correction more reliably than with the devices available today.”
Axis Spine Technologies raised £2.2 million (~USD $3.1 million) in a funding round. Axis is developing the next generation of Anterior Spinal Implant technology which provides surgeons with increased correction and alignment options.
The modular devices are inserted with less force than conventional implants to reduce the risks of...
Axis Spine Technologies raised £2.2 million (~USD $3.1 million) in a funding round. Axis is developing the next generation of Anterior Spinal Implant technology which provides surgeons with increased correction and alignment options.
The modular devices are inserted with less force than conventional implants to reduce the risks of structural damage which can lead to subsidence, an under-reported and recognized complication.
In 2020, the company received £830,000 (~USD $1.0 million) in new funding to bring products to the spine market, followed by FDA 510(k) clearance to market Axis-ALIF, their first implant system.
The funding will be used to support product launch and also development of oblique and lateral cage implants, as well as a highly differentiated access system.
Jon Arcos, Founder and CEO of Axis, said, “In 2021 we will take a big step forward in our mission to help surgeons improve the spinal care they provide to their patients. Our products will enable them to achieve superior correction and to maintain this correction more reliably than with the devices available today.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
